Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 3, 2012, Pages 252-258

  Wheat, Jeffery C ^a   Weizer, Alon Z ^a   Wolf, J Stuart ^a   Lotan, Yair ^b   Remzi, Mesut ^c   Margulis, Vitaly ^d   Wood, Christopher G ^d   Montorsi, Francesco ^e   Roscigno, Marco ^e   Kikuchi, Eiji ^f   Zigeuner, Richard ^g   Langner, Cord ^g   Bolenz, Christian ^h   Koppie, Theresa M ⁱ   Raman, Jay D ^j   Fernández, Mario ^k   Karakiewizc, Pierre ^l   Capitanio, Umberto ^l   Bensalah, Karim ^m   Patard, Jean Jacques ^m   Shariat, Shahrokh F ⁿ   more..

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f KEIO UNIVERSITY   (Japan)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j WEILL CORNELL MEDICAL COLLEGE   (United States)

^k UNIVERSIDAD DEL DESARROLLO   (Chile)

^l UNIVERSITÉ DE MONTRÉAL   (Canada)

^m UNIVERSITÉ DE RENNES 1   (France)

ⁿ LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

Carcinoma in situ; Nephroureterectomy; Transitional cell carcinoma; Upper tract

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL FEATURE; FEMALE; HUMAN; KIDNEY PELVIS TUMOR; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; URETER TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA IN SITU; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEPHRECTOMY; PALPATION; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK; URETER; URINARY BLADDER NEOPLASMS; URINARY TRACT; UROTHELIUM;

EID: 84860269295     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.01.001     Document Type: Article

References (8)

1. Munoz J.J., Ellison L.M. Upper tract urothelial neoplasms: Incidence and survival during the last 2 decades. J Urol 2000, 164:1523-1525.
2. Tawfiek E.R., Bagley D.H. Upper-tract transitional cell carcinoma. Urology 1997, 50:321-329.
3. Skinner D.G., Richie J.P., Cooper P.H., et al. The clinical significance of carcinoma in situ of the bladder and its association with overt carcinoma. J Urol 1974, 112:68-71.
4. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 2007, 51:152-160.
5. Millán-Rodríguez F., Chéchile-Toniolo G., Salvador-Bayarri J., et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000, 163:73-78.
6. Althausen A.F., Prout G.R., Daly J.J. Noninvasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 1976, 116:575-580.
7. Karam J.A., Margulis V., Montorsi F., et al. Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy-results from a multicenter study. Eur Urol 2008, 54:961-963.
8. Shariat S.F., Karakiewicz P.I., Palapattu G.S., et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 2006, 12:6663-6676.